In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, The George Washington University Office of CEHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that all conflicts of interest be identified, resolved, and communicated to learners prior to delivery of the activity. The following faculty and CME staff members, upon submission of a disclosure form, made no disclosures of commercial relationships:

Faculty (Speakers):

•    David Aronoff, MD
•    Taison Bell, MD
•    Karen C. Bloch, MD, MPH, FIDSA, FACP
•    Helen Boucher, MD
•    Henry F. Chambers, MD
•    Shireesha Dhanireddy, MD
•    Susan Dorman, MD
•    Roy M. Gulick, MD, MPH
•    Steven M. Holland, MD
•    Frank Maldarelli, MD
•    Edward Mitre, MD
•    Sandra Nelson, MD
•    Michael Saag, MD
•    Allan R. Tunkel, MD, PhD, MACP
•    Robert A. Weinstein, MD


•    John E. Bennett, MD
•    Henry Masur, MD
     *Both planners also resolved financial disclosures


•    Leticia Hall
•    Naomi Loughlin
•    Sheena P. King

The following faculty members (speakers) disclosed commercial relationships:

Paul G. Auwaerter, MD

  • Scientific Advisory Board: DiaSorin, Adaptive BioTherapeutics
  • Grantee: MicroBplex, NIH/SBIR (Lyme disease diagnostics)
  • Equity: JNJ

Rajesh Gandhi, MD

  • Scientific Advisory Board: Merck
  • Honorarium: Merck

Khalil G. Ghanem, MD

  • UpToDate royalties for topics related to STDs

Robin Patel, MD

  • Grantee: CD Diagnostics, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, ContraFect, TenNor Therapeutics Limited, Shionogi
  • Consulting: Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST, Qvella, Mayo Clinic
  • Patent-holder: Bordetella pertussis/parapertussis PCR, A device/method for sonication with royalties paid by Samsung to Mayo Clinic, Anti-biofilm substance
  • Travel reimbursement: ASM, IDSA
  • Editor’s stipend: IDSA
  • Honorarium: NBME, Up-to-Date, Infectious Diseases Board Review Course

Andrew T. Pavia, MD

  • Commercial Interests: Antimicrobial Therapy Inc, WebMD, Genentech, Merck

David Thomas, MD, MPH

  • Consulting: Merck and Co (Zoster Vaccine)

Richard J. Whitley, MD

  • Member of the Board of Directors and the Health Policy Advisory Board: Gilead Sciences
  • Chairperson: GlaxoSmithKline Independent Data Management Committee for Zoster Protocol 047
  • Chairperson: Merck Letermovir DSMB

Kevin L. Winthrop, MD

  • Reasearch; Insmed
  • Consulting: Insmed, Johnson&Johnson, Paratek, Red Hill Biopharma, Horizon